Stock Price Quote

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE165.051.75 (+1.07 %)
PREV CLOSE ( ) 163.30
OPEN PRICE ( ) 165.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 123811
TODAY'S LOW / HIGH ( )164.50 170.70
52 WK LOW / HIGH ( )144.95 336.4
NSE165.101.75 (+1.07 %)
PREV CLOSE( ) 163.35
OPEN PRICE ( ) 164.80
BID PRICE (QTY) 165.10 (9599)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 945270
TODAY'S LOW / HIGH( ) 164.45 170.70
52 WK LOW / HIGH ( )144.75 336.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1985
Management Info
Kamal K Sharma - Chairman Manish Gupta - Managing Director
Registered Office

Address 301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) ,
Thane,
Maharashtra-400604

Phone 022 4111 4777

Email pidsecretarial@yahoo.co.in

Website www.sequent.in

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

17Jan Announcement under Regulation 30 (LOD
Dear Sir / Madam, We enclose herewith a copy of Press Release titled..
15Jan Sequent Scientific informs about pres
Sequent Scientific has informed that it enclosed a copy of Press Release..
15Jan Sequent Scientific informs about chang
Sequent Scientific has informed that the Board of Directors of the Compa..
14Jan Announcement under Regulation 30 (LOD
Pursuant to Regulation 30 read with Part A, Schedule III of the SEBI (Li..
14Jan Announcement under Regulation 30 (LOD
Pursuant to Regulation 30 read with Part A, Schedule III of the SEBI (Li..

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit42.87321.13
Gross Profit 30.1 408.87
Operating Profit 58.29552.56
Net Sales 501.052654.57

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7230.70 (3.23%)
M.Cap ( in Cr)16652.75
Piramal Enterprises (BSE)
peergroup  2368.15 (2.80%)
M.Cap ( in Cr)56519.13
SMS Lifesciences (BSE)
peergroup  750.90 (7.11%)
M.Cap ( in Cr)227.02
Pfizer (BSE)
peergroup  4483.55 (1.02%)
M.Cap ( in Cr)20511.22
Procter&Gamble Healt (BSE)
peergroup  5094.25 (0.75%)
M.Cap ( in Cr)8456.14

Shareholding Pattern

PROMOTERS 53.02%
NON-INSTITUTION 38.43%
MUTUAL FUNDS/UTI 0.51%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Sequent Scientific Ltd.

Sequent Scientific Ltd. was incorporated in the year 1985. Its today's share price is 165.05. Its current market capitalisation stands at Rs 4099.36 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2686.92 Cr and Total Income of Rs.2854.23 Cr. The company's management includes Sharat Narasapur, Manish Gupta, Rahul Mukim, Neeraj Bharadwaj, Gregory John Andrews, Fabian Kausche, Krunal Shah, Kausalya Santhanam, Milind Sarwate, Kamal K Sharma.

It is listed on the BSE with a BSE Code of 512529 , NSE with an NSE Symbol of SEQUENT and ISIN of INE807F01027. It's Registered office is at 301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) Thane-400604, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)